Company: AMWL
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057290
Chunk: 35

Company: American Well Corp
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 35
---
 a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, in each case, to the fullest extent permitted under the DGCL.

Transactions with Others

Dr. Ido Schoenberg’s son, Dan Wahrhaft, is employed with the Company as Vice President, Sales & Account Management. Mr. Wahrhaft received aggregate compensation, inclusive of his base salary, bonus, equity awards granted and Company contribution under the Company’s defined contribution retirement plan, of $209,152 for his employment in the year ended December 31, 2024.

<div align='center'>19</div>

EXECUTIVE OFFICERS The following table sets forth certain information about our executive officers and their respective ages as of March 31, 2025. Officers are elected by the Board to hold office until their successors are appointed and qualified.

| Name                    |     | Age |    |     | Position                                            |
| Ido Schoenberg, MD      |     |     | 60 |     | Chairman, Chief Executive Officer                   |
| Roy Schoenberg, MD, MPH |     |     | 57 |     | Executive Vice Chairman                             |
| Phyllis Gotlib          |     |     | 68 |     | President, International                            |
| Mark Hirschhorn         |     |     | 60 |     | Chief Financial Officer and Chief Operating Officer |
| Dmitry (Dan) Zamansky   |     |     | 41 |     | Chief Product & Technology Officer                  |

For the biographies of Drs. Ido Schoenberg and Roy Schoenberg, see the section titled “Board of Directors and Corporate Governance—Continuing Directors.” Phyllis Gotlib, President, American Well International Since January 2018, Ms. Gotlib has led Amwell’s international operations. Prior to joining Amwell, Phyllis was Executive Partner at Flare Capital. She also served as co-founder and CEO of iMDsoft, a disruptive clinical information technology company that created innovative, market-leading solutions to streamline and optimize hospitals’ high-acuity care. Phyllis led iMDsoft from inception through its exponential international growth and ultimately to its acquisition by TPG Growth in 2012. Prior to iMDsoft, she founded PS Gluck, a lucrative diamond trade company which she managed for many years with her partner in the